Adding Lynparza to Presurgical Chemo May Not Boost TNBC Outcomes
The addition of Lynparza to presurgical chemotherapy did not improve outcomes for patients with basal-like BRCA wild-type triple-negative breast cancer.
Source: curetoday.com
Stay updated with breaking news from Adding Lynparza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The addition of Lynparza to presurgical chemotherapy did not improve outcomes for patients with basal-like BRCA wild-type triple-negative breast cancer.